12:00 PM - 1:00 PM
July 18, 2018
The Blurring Line Between Big Pharma and Nutraceuticals
The line between nutraceuticals, OTC and pharma is being redefined. Active and engaged on that blurring line, this panel of experts will explore what’s coming and how we might re-envision DSHEA to take the industry where it needs to go to realize the goal of changing healthcare. Defining the right science and how it fits with the right claims will be pivotal to turn nutrition into a medically accepted strategy for challenging health concerns Americans must face. This session will provide a progress report and a roadmap to realizing these important changes.